Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EXTEND: Alteplase in Acute Ischaemic Stroke
NCT01580839Phase 3Completed
- Sponsor
- Neuroscience Trials Australia
- Start
- Dec 2012
- Primary completion
- Aug 2018
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of tissue-plasminogen activator in acute ischemic stroke (AIS), sponsored by Neuroscience Trials Australia. Started Dec 2012; status: completed.
02
Drugs
tissue-plasminogen activator
03
Conditions
acute ischemic stroke (AIS)
Beyond the preview
Go deeper on NCT01580839.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01580839.